Literature DB >> 2702565

Chemotherapy in the management of intraocular lymphoma.

J A Strauchen1, J Dalton, A H Friedman.   

Abstract

Six patients with intraocular (vitreous) lymphomas were treated with high-dose intravenous cytosine arabinoside (Ara-C). Four patients were previously untreated, one patient had previously received ocular and central nervous system radiation therapy and relapsed, and one patient had previously received chemotherapy for systemic lymphoma. Five responses were observed: one complete and four partial. High-dose Ara-C is active in intraocular (vitreous) lymphoma, but complete response is uncommon. Adjunctive use of Ara-C in combination with ocular irradiation may be a useful form of therapy in this uncommon lymphoma.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2702565     DOI： 10.1002/1097-0142(19890515)63:10<1918::aid-cncr2820631008>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  13 in total

Review 1.  Management of primary intraocular lymphoma.

Authors:  Stella K Kim; Chi-Chao Chan; Dana J Wallace
Journal:  Curr Oncol Rep       Date:  2005-01       Impact factor: 5.075

Review 2.  Primary intraocular lymphoma: a review.

Authors:  Gregory S Vosganian; Saskia Boisot; Kathrin I Hartmann; William R Freeman; Robert W Sharpe; Prabhakar Tripuraneni; Alan Saven
Journal:  J Neurooncol       Date:  2011-05-31       Impact factor: 4.130

Review 3.  Primary CNS lymphoma: findings outside the brain.

Authors:  U Herrlinger
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

Review 4.  Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features.

Authors:  Sarah E Coupland; Heinrich Heimann; Nikolaos E Bechrakis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-10-29       Impact factor: 3.117

5.  Chemotherapy in newly diagnosed primary central nervous system lymphoma.

Authors:  Nooshin Hashemi-Sadraei; David M Peereboom
Journal:  Ther Adv Med Oncol       Date:  2010-07       Impact factor: 8.168

6.  Intraocular lymphoma 2000-2005: results of a retrospective multicentre trial.

Authors:  Kristoph Jahnke; Agnieszka Korfel; Julia Komm; Nikolaos E Bechrakis; Harald Stein; Eckhard Thiel; Sarah E Coupland
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-16       Impact factor: 3.117

Review 7.  Treatment of primary intraocular lymphoma with oral trofosfamide: report of two cases and review of the literature.

Authors:  Kristoph Jahnke; Nikolaos E Bechrakis; Sarah E Coupland; Alexander Schmittel; Michael H Foerster; Lars Fischer; Eckhard Thiel; Agnieszka Korfel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09       Impact factor: 3.117

Review 8.  Intraocular lymphoma: update on diagnosis and management.

Authors:  Chi-Chao Chan; Dana J Wallace
Journal:  Cancer Control       Date:  2004 Sep-Oct       Impact factor: 3.302

9.  Methotrexate based chemotherapy and deferred radiotherapy for primary central nervous system lymphoma (PCNSL): single institution experience.

Authors:  A Silvani; A Salmaggi; M Eoli; E Lamperti; G Broggi; C E Marras; L Fariselli; I Milanesi; A Fiumani; P Gaviani; A Erbetta; A R Giovagnoli; B Pollo; A Botturi; A Boiardi
Journal:  J Neurooncol       Date:  2006-11-17       Impact factor: 4.506

Review 10.  Primary nervous system lymphoma.

Authors:  Scott R Plotkin; Tracy T Batchelor
Journal:  Curr Treat Options Oncol       Date:  2002-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.